An announcement from Galapagos ( (NL:GLPG) ) is now available.
Galapagos has published its 2024 annual report and announced its Annual Shareholders’ Meeting scheduled for April 29, 2025. Key agenda items include the appointment of a new Non-Executive Non-Independent Director and the confirmation of the statutory auditor for sustainability reporting. The proposed separation into two publicly traded entities will be discussed in a future meeting.
More about Galapagos
Galapagos is a biotechnology company operating in Europe and the U.S., focusing on transforming patient outcomes through innovative science. The company addresses high unmet medical needs by developing a pipeline of best-in-class medicines, utilizing a decentralized cell therapy manufacturing platform, and aiming to shape the future of healthcare.
YTD Price Performance: -9.93%
Average Trading Volume: 10,042
Technical Sentiment Signal: Strong Buy
Current Market Cap: €1.56B
For detailed information about GLPG stock, go to TipRanks’ Stock Analysis page.